Clinical Trial Update: Study of Aminolevulinic Acid to Enhance Visualization and Resection of Malignant Glial Tumors of the Brain [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating aminolevulinic acid to enhance visualization and surgical resection of malignant glial brain tumors; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor
• Glioblastoma
• Glioma
• Malignant Glioma

Drugs mentioned

• Aminolevulinic acid (5-aminolevulinic acid)

Snippet

Sponsor: Advocate Hospital System | Conditions: Brain Tumors | Phase 1 | Status: COMPLETED